Systematic review of radiomic biomarkers for predicting immune checkpoint inhibitor treatment outcomes

This publication has 44 references indexed in Scilit:

• Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
  The Lancet, 2016
• Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
  Nature Communications, 2016
• Radiomics: Images Are More than Pictures, They Are Data
  Radiology, 2016
• Radiomics: Extracting more information from medical images using advanced feature analysis
  European Journal of Cancer, 2012
• Search Filters for Finding Prognostic and Diagnostic Prediction Studies in Medline to Enhance Systematic Reviews
  PLOS ONE, 2012
• PRISMA Statement
  Epidemiology, 2011
• Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging
  European Journal of Radiology, 2009
• Sorafenib in Advanced Hepatocellular Carcinoma
  New England Journal of Medicine, 2008
• Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey
  BMJ, 2005
• The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews
  BMC Medical Research Methodology, 2003